Efficacy and Safety of 177Lu-Dotatate PRRT in Metastatic GEP-NEN Patients

NCT03422029 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Peking University